ATE401342T1 - Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden - Google Patents

Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden

Info

Publication number
ATE401342T1
ATE401342T1 AT99950055T AT99950055T ATE401342T1 AT E401342 T1 ATE401342 T1 AT E401342T1 AT 99950055 T AT99950055 T AT 99950055T AT 99950055 T AT99950055 T AT 99950055T AT E401342 T1 ATE401342 T1 AT E401342T1
Authority
AT
Austria
Prior art keywords
albumin
marker
measurement
detection
detecting
Prior art date
Application number
AT99950055T
Other languages
English (en)
Inventor
David Bar-Or
Edward Lau
Original Assignee
Ischemia Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26799929&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE401342(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/165,961 external-priority patent/US6475743B1/en
Application filed by Ischemia Tech Inc filed Critical Ischemia Tech Inc
Application granted granted Critical
Publication of ATE401342T1 publication Critical patent/ATE401342T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Investigating And Analyzing Materials By Characteristic Methods (AREA)
AT99950055T 1998-10-02 1999-10-01 Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden ATE401342T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10296298P 1998-10-02 1998-10-02
US09/165,961 US6475743B1 (en) 1998-10-02 1998-10-02 Marker useful for detection and measurement of free radical damage and method

Publications (1)

Publication Number Publication Date
ATE401342T1 true ATE401342T1 (de) 2008-08-15

Family

ID=26799929

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99950055T ATE401342T1 (de) 1998-10-02 1999-10-01 Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden

Country Status (5)

Country Link
EP (1) EP1117686B1 (de)
AT (1) ATE401342T1 (de)
AU (1) AU6279399A (de)
DE (1) DE69939121D1 (de)
WO (1) WO2000020454A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475743B1 (en) 1998-10-02 2002-11-05 Ischemia Technologies, Inc. Marker useful for detection and measurement of free radical damage and method
US7449338B2 (en) 1998-10-02 2008-11-11 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US6492179B1 (en) 1998-10-02 2002-12-10 Ischemia Techologies, Inc. Test for rapid evaluation of ischemic states and kit
US6461875B1 (en) 1998-10-02 2002-10-08 Ischemia Technologies, Inc. Test for rapid evaluation of ischemic states and kit
JP2002526764A (ja) * 1998-10-02 2002-08-20 イスケミア・テクノロジーズ・インコーポレーテッド 虚血状態の迅速鑑定のための検査およびキット
US7070937B1 (en) 1998-10-02 2006-07-04 Ischemia Technologies, Inc. Marker useful for detection and measurement of free radical damage and method
US7297544B2 (en) 1998-10-02 2007-11-20 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US7829072B2 (en) 2000-07-14 2010-11-09 Carter Daniel C Serum albumin compositions for use in cleansing or dermatological products for skin or hair
US6787636B1 (en) 2000-07-14 2004-09-07 New Century Pharmaceuticals, Inc. Modified serum albumin with reduced affinity for nickel and copper
EP1311269B1 (de) 2000-08-04 2012-02-29 DMI Biosciences, Inc. Verfahren zur verwendung von diketopiperazinen und zusammensetzungen, die diese enthalten
AU2002305731A1 (en) * 2001-05-30 2002-12-09 Ischemia Technology, Inc. Method and system for optically performing an assay to determine a medical condition
JP2005510712A (ja) 2001-11-26 2005-04-21 イスケミア・テクノロジーズ・インコーポレーテッド 虚血の電気化学的検知
DK1571970T3 (da) * 2002-10-02 2011-11-28 Dmi Biosciences Inc Diagnose og monitorering af sygdomme
NZ582769A (en) * 2002-10-09 2011-11-25 Dmi Biosciences Inc Diagnosis and monitoring of inflammation, ischemia and appendicitis
ES2572975T3 (es) 2003-05-15 2016-06-03 Ampio Pharmaceuticals, Inc. Tratamiento de enfermedades mediadas por los linfocitos T
US7074194B2 (en) 2003-05-19 2006-07-11 Ischemia Technologies, Inc. Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin
EP2300011A4 (de) 2008-05-27 2012-06-20 Dmi Life Sciences Inc Therapeutische verfahren und verbindungen
US8507496B2 (en) 2010-09-07 2013-08-13 Dmi Acquisition Corp. Treatment of diseases
EP3721884A1 (de) 2011-10-10 2020-10-14 Ampio Pharmaceuticals, Inc. Behandlung degenerativer gelenkerkrankung mit da-dkp (= aspartly-alanyl-diketopiperazin)
US9925300B2 (en) 2011-10-10 2018-03-27 Ampio Pharmaceuticals, Inc. Implantable medical devices with increased immune tolerance, and methods for making and implanting
WO2013063413A1 (en) 2011-10-28 2013-05-02 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
CA2906864A1 (en) 2013-03-15 2014-09-18 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
JP6723222B2 (ja) 2014-08-18 2020-07-15 アンピオ ファーマシューティカルズ，インコーポレイテッド 関節病態の治療
WO2016209969A1 (en) 2015-06-22 2016-12-29 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
TWI568746B (zh) * 2016-07-06 2017-02-01 高雄醫學大學 用以評估自由基產生能力的寡肽及方法

Also Published As

Publication number Publication date
AU6279399A (en) 2000-04-26
DE69939121D1 (de) 2008-08-28
EP1117686A4 (de) 2005-01-12
EP1117686B1 (de) 2008-07-16
EP1117686A1 (de) 2001-07-25
WO2000020454A1 (en) 2000-04-13

Similar Documents

Publication Publication Date Title
ATE401342T1 (de) Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden
US5585277A (en) Screening method for identifying ligands for target proteins
DE60118527D1 (de) Sensible und multiplexe diagnostische tests zur proteinanalyse
RU95108591A (ru) Способ определения состояния сепсисного заболевания
CA2480466A1 (en) Detection and/or monitoring of synuclein-related diseases
ATE160875T1 (de) Verfahren zum nachweis und/oder zur bestimmung und/oder zur isolierung von apoptotischen zellen in oder aus einer probe
WO2002082075A3 (de) Verfahren zum nachweis chronisch-demenzieller erkrankungen, zugehörige peptide und nachweisreagenzien
DE69607176D1 (de) Verfahren zur quantitativen bestimmung menschlichen akutphasen-serum-amyloid-a-proteins; rekombinantes protein; spezifischer antikörper
Friedman Comparison of four different silver-staining techniques for salivary protein detection in alkaline polyacrylamide gels
Dukhanina et al. Spectral studies on the calcium-binding properties of Mts1 protein and its interaction with target protein
DE60025170D1 (de) Diagnostisches verfahren für asthma
US11280783B2 (en) Devices and methods related to airway inflammation
ATE284034T1 (de) Verfahren zum nachweis von protein s
EP1945798B1 (de) Verfahren zur bestimmung der spaltbarkeit von substraten
CA2366651A1 (en) A method for detecting megsin protein and use thereof
Willan et al. Comparison of the dimensions of the combining sites of the dinitrophenyl-binding immunoglobulin A myeloma proteins MOPC 315, MOPC 460 and XRPC 25 by spin-label mapping
WO2004082455A3 (en) Method for detecting alzheimer’s disease and corresponding peptides and detection reagents
AU2007200433B2 (en) Biomolecular toxicity assay
CA2344762A1 (en) Tests for the rapid evaluation of ischemic states and kits
WO1999045388A1 (en) Test for analyzing a sample
JPS5995460A (ja) リューマチ性疾病の検査方法および試験キット
WO2004054431A3 (en) Tests for the rapid evaluation of ischemic states and kits
JP4460779B2 (ja) ホスファターゼ標的毒素のアッセイ
JP6961101B2 (ja) ウイルスおよび細菌の感染症を識別するための方法およびデバイス
ATE347108T1 (de) Zusammensetzungen und verfahren zum bestimmen von aa4rp

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties